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Abstract
Introduction: Bordetella bronchiseptica can be a cause of virulent pneumonia in humans with
impaired immune systems. Few cases have been reported in the medical literature where Bordetella
bronchiseptica has been the only pathogen isolated during a course of interstitial pneumonia.
Case presentation: A 42-year-old African-American man with human immunodeficiency virus
presented with pulmonary symptoms that mimicked Pneumocystis jiroveci pneumonia. A sputum
culture grew Bordetella brochiseptica, a common respiratory commensal of wild and domestic
animals, rarely implicated in human infections.
Conclusion: Bordetella bronchiseptica should be added to the differential list of pathogens which
can affect people with human immunodeficiency virus and pulmonary symptoms. Sputum culture,
as well as history of animal exposure, in these patients is advised.
Introduction
Bordetella bronchiseptica is a common pathogen in the res-
piratory tract of many wild and domestic animals, but it is
rarely found in humans [1]. This pathogen is believed to
be transmitted from dogs with tracheobronchitis [2]. Bor-
detella bronchiseptica is considered an etiologic agent of
upper respiratory tract infections, pneumonitis, endocar-
ditis, peritonitis, meningitis, sepsis and recurrent bacter-
aemia in people with immunological abnormalities [3].
In human immunodeficiency virus and/or acquired
immunodeficiency syndrome (HIV/AIDS) patients, Borde-
tella bronchiseptica can cause an interstitial pneumonia
which can resemble pneumocystis pneumonia.
Case presentation
A 42-year-old African-American man with HIV/AIDS, not
taking any medications including HAART and pneumo-
cystis jiroveci prophylaxis since January 2007, presented
in August 2007 with complaints of progressing shortness
of breath, right-sided pleuritic chest pain, non-productive
cough, and low-grade fever for last several weeks. He was
diagnosed with HIV initially in 1999, during hospitaliza-
tion for community-acquired pneumonia. The patient
also had a history of facial herpes simplex virus type 2
(HSV-2) which has been recurrent and a history of pneu-
mocystis pneumonia in June 2005. Previous laboratory
studies from November 2006 revealed a CD4+ lym-
phocyte count of 20 and viral load HIV RNA of 65,833
copies/ml. He was a social drinker and had never used
illicit drugs or tobacco products. HIV was presumed to be
acquired sexually.
On initial assessment in the emergency department, he
was cachectic but was in no acute distress. He had a fever
of 38°C, blood pressure of 92/60 mmHg and regular
pulse of 85 beats per minute. He was breathing at 20
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breaths per minute. Oxygen saturation was 95% on room
air, which decreased to 90% during ambulation. There
were no oral lesions. His neck was supple. Examination of
the lungs revealed bilateral expiratory wheezes and rare
rhonchi. Cardiac examination demonstrated normal first
sound, second sound with a regular rhythm and no mur-
murs. His abdomen was soft, nontender, nondistended
with normoactive bowel sounds. His extremities were
warm and his skin was dry with multiple small herpetic
ulcers on the left ear and the left side of the face.
Laboratory tests revealed the following concentrations:
sodium 138 mmol/L, potassium 4.5 mmol/L, chloride
103 mmol/L, bicarbonate 26 mmol/L, BUN 2.9 mmol/L,
creatinine 61 μmol/L, glucose 4.78 mmol/L, white blood
cell 3.4 × 109/L, neutrophils 86%, hemoglobin 7.1 mmol/
L, hematocrit 33%, platelets 322 × 109/L, LDH 497 U/L,
CD4+ lymphocyte count of 2. Chest X-ray was negative for
infiltrate (Figure 1), but high resolution CT of the chest
revealed subtle right middle lobe and right upper lobe
ground-glass opacity (Figure 2).
The patient was admitted to the medical ward with a
working diagnosis of pneumocystis pneumonia. A spu-
tum sample was collected spontaneously for a culture
work-up (Bartlett score: +3). No sputum sample was col-
lected for mycobacterial stains. Empiric treatment with tri-
methoprim-sulfamethoxazole (1 tablet double-strength ×
3 per day) and prednisone (40 mg × 2 per day) was
started. The patient was also placed on treatment for HSV
with acyclovir (400 mg × 3 per day). The prednisone doses
were reduced as part of initial therapy for pneumocystis
pneumonia. On the third day, direct fluorescent antibody
test for Pneumocystis jiroveci was negative, but the culture
was positive for Bordetella bronchiseptica. The patient was
placed on droplet precautions; treatment was switched to
levofloxacin (400 mg per day). Trimethoprim-sulfameth-
oxazole dose was modified to (1 tablet single-strength per
day) for pneumocystis prophylaxis and azithromycin
(1200 mg once per week) for Mycobacterium avium complex
prophylaxis began. The patient subsequently improved
on levofloxacin and on the seventh day was discharged
home on levofloxacin, trimethoprim-sulfamethoxazole,
azithromycin, and acyclovir. After eleven days, the patient
visited our office. The patient had no complaints, no fever
and no cough and his shortness of breath was fully
resolved. On retrospect, the patient reported that he had
been visited by his brother and his brother's dog at his
home about a week prior to the illness.
Discussion
Culture study of sputum revealed that the causative path-
ogen of pneumonia in our patient was Bordetella bron-
chiseptica. This is a pleomorphic Gram-negative
coccobacillus which is a common respiratory tract patho-
gen in many domestic and wild animals which causes res-
piratory diseases in a broad variety of mammal species [4].
The route of transmission has not been clearly estab-
lished. Occupational exposure to kenneled dogs in one
case was documented [5]. A "kennel cough", also known
as nonproductive paroxysmal cough, is a highly conta-
gious form of tracheobronchitis in dogs [2]. Bordetella
bronchiseptica has been also isolated as a human commen-
sal, notably from the respiratory tract. There have been
several cases reported in the literature in which Bordetella
bronchiseptica was a causative agent of infection among
humans. These range from acute iatrogenic maxillary
sinusitis and tracheobronchitis to acute pneumonia and
pneumonia with septicemia. This organism is typically a
pathogen of immunocompromised hosts such as people
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who abuse alcohol, people with diabetes, patients with
Hodgkin's disease or chronic lymphocytic leukemia and
patients with HIV/AIDS [6].
Infection due to Bordetella bronchiseptica is uncommon in
HIV-infected people. Respiratory illnesses ranged in sever-
ity from mild upper respiratory tract infection to pneumo-
nia. There have been a few reports in the literature across
decades, describing pneumonias in immunocompro-
mised HIV-infected patients caused by Bordetella bron-
chiseptica. Medical records of over 41,000 patients with
HIV researched by Dworkin et al. revealed that nine of the
patients had been diagnosed with a Bordetella bronchisep-
tica  infection during 1991-1998. Five patients suffered
from pneumonia but Bordetella Bronchiseptica was the only
pathogen isolated from a culture specimen in only two of
the patients.
Presence of the pathogen was confirmed by specimen cul-
ture obtained by nasal swab, sputum or bronchoscopy. All
patients had a CD4+ lymphocyte count less than 200.
Most of these infections were treated successfully based on
the antibiotic susceptibility pattern [5], although this
pathogen when unrecognized and treated improperly can
be fatal [7].
Conclusion
Our case report points out the importance of a thorough
culture work-up when caring for immunocompromised
patients with HIV. The report also stress the importance of
eliciting data of animal exposure. Physicians should rec-
ommend avoidance of unknown animals, as well as
proper health care and vaccination of pets. We believe that
Bordetella bronchiseptica, because of its similar presentation
to pneumocystis pneumonia, should be considered in the
differential diagnosis of pneumonia in people with HIV.
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